Literature DB >> 6798975

Stimulation of production of prostaglandin E in gingival cells exposed to products of human blood mononuclear cells.

S M D'Souza, D J Englis, A Clark, R G Russell.   

Abstract

1. Supernatant media from cultures of unstimulated human peripheral blood mononuclear cells contained one or more factors that increased by several hundred-fold the production of prostaglandin E by fibroblast-like cells derived from both inflamed and normal human gingival tissue. 2. This stimulation occurred in a dose-dependent manner and was completely inhibited by 14 microM-indomethacin. 3. Responsiveness to the factor declined as the age of the cell culture increased. 4. An increase in prostaglandin E production was first observed after a 2h exposure to the mononuclear cell factor(s) and could be prevented by cycloheximide. 5. Brief exposure (0.5 and 1.0 h) to mononuclear cell factor did not increase prostaglandin E production by the cells in a subsequent 72 h incubation in the absence of mononuclear cell factor. 6. Addition of arachidonate (10 microM and 15 microM) further enhanced stimulation of prostaglandin E production in response to mononuclear cell factor. 7. The stimulatory activity was resistant to digestion by trypsin, but was heat-labile, so that only 17% remained after treatment at 56 degrees C for 30 min.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6798975      PMCID: PMC1163261          DOI: 10.1042/bj1980391

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  13 in total

1.  Initial gingivitis in dogs.

Authors:  H E Schroeder; M Graf-de Beer; R Attström
Journal:  J Periodontal Res       Date:  1975-07       Impact factor: 4.419

2.  Measurement of cell growth in tissue culture with a phenol reagent (folin-ciocalteau).

Authors:  V I OYAMA; H EAGLE
Journal:  Proc Soc Exp Biol Med       Date:  1956-02

3.  Effect of prostaglaidin endoperoxides and metabolites on bone resorption in vitro.

Authors:  L G Raisz; J W Dietrich; H A Simmons; H W Seyberth; W Hubbard; J A Oates
Journal:  Nature       Date:  1977-06-09       Impact factor: 49.962

4.  Prostaglandin E2 levels and human periodontal disease.

Authors:  J M Goodson; F E Dewhirst; A Brunetti
Journal:  Prostaglandins       Date:  1974-04-10

5.  Inhibition of bone collagen synthesis by prostaglandin E2 in organ culture.

Authors:  L G Raisz; A R Koolemans-Beynen
Journal:  Prostaglandins       Date:  1974-12-10

6.  Prostaglandins: stimulation of bone resorption in tissue culture.

Authors:  D C Klein; L G Raisz
Journal:  Endocrinology       Date:  1970-06       Impact factor: 4.736

7.  Macrophage-lymphocyte synergy in the production of osteoclast activating factor.

Authors:  J E Horton; J J Oppenheim; S E Mergenhagen; L G Raisz
Journal:  J Immunol       Date:  1974-10       Impact factor: 5.422

8.  Bone resorbing activity in supernatant fluid from cultured human peripheral blood leukocytes.

Authors:  J E Horton; L G Raisz; H A Simmons; J J Oppenheim; S E Mergenhagen
Journal:  Science       Date:  1972-09-01       Impact factor: 47.728

9.  Biological activities of prostaglandin analogues and metabolites on bone in organ culture.

Authors:  A H Tashjian; J E Tice; K Sides
Journal:  Nature       Date:  1977-04-14       Impact factor: 49.962

10.  Prostaglandin production by rheumatoid synovial cells: stimulation by a factor from human mononuclear Cells.

Authors:  J M Dayer; D R Robinson; S M Krane
Journal:  J Exp Med       Date:  1977-05-01       Impact factor: 14.307

View more
  2 in total

1.  Mechanism of enhanced fibroblast arachidonic acid metabolism by mononuclear cell factor.

Authors:  P J Whiteley; P Needleman
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

2.  Metabolic and cellular alterations underlying the exaggerated renal prostaglandin and thromboxane synthesis in ureter obstruction in rabbits. Inflammatory response involving fibroblasts and mononuclear cells.

Authors:  T Okegawa; P E Jonas; K DeSchryver; A Kawasaki; P Needleman
Journal:  J Clin Invest       Date:  1983-01       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.